Based on the most recent clinical data, Tirzepatide has been shown to help people lose a lot of weightmore than 20% in some tests
Among patients prescribed semaglutide for diabetes, the hazard ratio was 4.28, while overweight or obese patients showed 7.64, with cumulative NAION incidence reaching 6.7% over 36 months compared to 0.8% for non-GLP-1 medications
In all but a small number of cases, patients receive a sedative and there is little or no discomfort
Semaglutide works by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which stimulates the release of insulin and helps to reduce blood sugar spikes
ERK1/2: extracellular signal-regulated kinase 1/2
Animal studies have demonstrated a variety of adverse effects during pregnancy, including decreased fetal growth, skeletal abnormalities and even miscarriage, she says